Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jun 23, 2026

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Expensify Inc (Class A)	David Barrett	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	2,094,974	2,094,974	-		-	Stock Option
Expensify Inc (Class A)	David Barrett	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	2,031,280	2,031,280	-		-	Stock Option
Expensify Inc (Class A)	Ryan Schaffer	Director, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	1,164,596	1,164,596	-		-	Stock Option
Expensify Inc (Class A)	Jason Mills	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	1,160,447	1,160,447	-		-	Stock Option
Expensify Inc (Class A)	Daniel Vidal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	1,160,447	1,160,447	-		-	Stock Option
Prospect Capital Corp	John F. Barry	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 2.27 per share.	23 Jun 2026	1,000,000	89,146,077 (24%)	0%	2.3	2,274,500	COMMON STOCK
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	880,000	1,212,293	-		-	Class B Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	880,000	1,360,866	-		-	Class A Common Stock
Wendy`s Co (Class A)	Steven W. Cirulis	CFO & Chf Strategy Ofc	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	707,811	707,811	-		-	Employee Stock Option (Right to Buy)
Oscar Health Inc (Class A)	Mario Schlosser	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	660,000	2,092,293	-		-	Class B Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	660,000	3,740,000	-		-	Stock Option (Right to Buy)
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 29.58 per share.	23 Jun 2026	591,213	482,665	-	29.6	17,488,081	Class A Common Stock
Fluent Inc	Matthew Conlin	Director, Chief Customer Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	454,648	0	-		-	Pre-Funded Warrant
Fluent Inc	Matthew Conlin	Director, Chief Customer Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	454,648	3,009,027 (3%)	0%	0.0	227	Common Stock
Fluent Inc	Ryan Schulke	Director, Chief Strategy Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	428,571	0	-		-	Pre-Funded Warrant
Fluent Inc	Ryan Schulke	Director, Chief Strategy Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	428,571	4,153,857 (5%)	0%	0.0	214	Common Stock
Prairie Operating Co	Gregory S. Patton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	425,000	1,116,224 (1%)	0%		0	Common Stock
Prairie Operating Co	Gregory S. Patton	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	425,000	425,000	-		-	Performance Units
Hyperliquid Strategies Inc	Jeroen Nieuwkoop	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	421,623	421,623	-		0	Common Stock
Trulieve Cannabis Corp	Kim A. Rivers	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 8.17 per share.	23 Jun 2026	400,000	1,913,724	-	8.2	3,267,600	Subordinate Voting Shares
Trulieve Cannabis Corp	Kim A. Rivers	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 8.47 per share.	23 Jun 2026	380,000	2,313,724	-	8.5	3,218,220	Subordinate Voting Shares
Trulieve Cannabis Corp	Kim A. Rivers	Director, Chairman and CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 8.17 per share.	23 Jun 2026	300,000	1,613,724	-	8.2	2,450,700	Subordinate Voting Shares
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 28.95 per share.	23 Jun 2026	286,988	1,073,878	-	29.0	8,308,303	Class A Common Stock
Fluent Inc	Ryan Schulke	Director, Chief Strategy Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	227,324	0	-		-	Pre-Funded Warrant
Fluent Inc	Ryan Schulke	Director, Chief Strategy Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	227,324	3,725,319 (4%)	0%	0.0	114	Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	196,576	18,414,555	-		-	Non-voting common units of Alclear Holdings, LLC
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	196,576	0	-		-	Class A Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jun 2026	196,576	151,787	-		-	Class B Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	196,576	348,363	-		-	Class B Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jun 2026	196,576	18,414,555	-		-	Class D Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 53.21 per share.	23 Jun 2026	196,576	0	-	53.2	10,459,809	Class A Common Stock
OneMedNet Corp (Class A)	Jeffrey Yu	Director, Chief Medical Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 0.63 per share.	23 Jun 2026	158,730	8,780,410	-	0.6	100,000	Common Stock
Nuvation Bio Inc (Class A)	Stacy Markel	CHIEF PEOPLE OFFICER	Sale of securities on an exchange or to another person at price $ 6.03 per share.	23 Jun 2026	125,000	32,591	-	6.0	753,188	Class A Common Stock
FREYR Battery	Joseph Evan Calio	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	125,000	1,922,585	-		-	Common Stock
FREYR Battery	Joseph Evan Calio	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	125,000	250,000	-		-	Restricted Stock Units (RSUs)
Royalty Pharma PLC (Class A)	Christopher Hite	EVP & Chairman, Partnering	Sale of securities on an exchange or to another person at price $ 54.47 per share.	23 Jun 2026	117,592	559,399	-	54.5	6,405,777	Class A Ordinary Shares
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 120.66 per share.	23 Jun 2026	112,299	2,963,607	-	120.7	13,549,997	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner		23 Jun 2026	107,692	23,556,968	-		-	Class B Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner		23 Jun 2026	107,692	107,692	-		-	Class A Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 100.42 per share.	23 Jun 2026	103,688	3,357,833	-	100.4	10,412,349	Common Stock
Madison Air Solutions Corp	Jill S. Wyant	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.13 per share.	23 Jun 2026	93,618	3,472,415	-	38.1	3,569,654	Class A common stock
Nuvation Bio Inc (Class A)	Stacy Markel	CHIEF PEOPLE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.87 per share.	23 Jun 2026	90,380	122,971	-	1.9	169,011	Class A Common Stock
Nuvation Bio Inc (Class A)	Stacy Markel	CHIEF PEOPLE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	90,380	409,620	-		-	Stock Option (Right to Buy)
Fluent Inc	Matthew Conlin	Director, Chief Customer Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	85,714	2,554,391 (3%)	0%	0.0	43	Common Stock
Fluent Inc	Matthew Conlin	Director, Chief Customer Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	85,714	0	-		-	Pre-Funded Warrant
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 116.53 per share.	23 Jun 2026	81,500	3,156,442	-	116.5	9,497,195	Common Stock
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.13 per share.	23 Jun 2026	77,855	4,805,639	-	21.1	1,645,076	Common Stock
Prospect Capital Corp	John F. Barry	Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 2.27 per share.	23 Jun 2026	67,648	89,213,725 (24%)	0%	2.3	153,568	COMMON STOCK
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 106.04 per share.	23 Jun 2026	65,239	3,366,868	-	106.0	6,917,898	Class A Common Stock
Expensify Inc (Class A)	David Barrett	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	63,694	63,694	-		-	Stock Option
TeraWulf Inc Fundraise	Steven T. Pincus	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	63,026	399,391	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Steven T. Pincus	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	63,026	0	-		-	Restricted Stock Units
Nuvation Bio Inc (Class A)	Kerry Wentworth	CHIEF REGULATORY OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.93 per share.	23 Jun 2026	63,000	116,000	-	2.9	184,590	Class A Common Stock
Nuvation Bio Inc (Class A)	Kerry Wentworth	CHIEF REGULATORY OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	63,000	152,250	-		-	Stock Option (Right to Buy)
Nuvation Bio Inc (Class A)	Kerry Wentworth	CHIEF REGULATORY OFFICER	Sale of securities on an exchange or to another person at price $ 6.02 per share.	23 Jun 2026	63,000	53,000	-	6.0	379,191	Class A Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 115.57 per share.	23 Jun 2026	58,205	3,237,942	-	115.6	6,726,752	Common Stock
FREYR Battery	Joseph Evan Calio	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	23 Jun 2026	57,925	1,864,660	-	9.2	535,227	Common Stock
Fluent Inc	Matthew Conlin	Director, Chief Customer Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	57,143	0	-		-	Pre-Funded Warrant
Fluent Inc	Matthew Conlin	Director, Chief Customer Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	57,143	498,474 (0%)	0%	0.0	29	Common Stock
TeraWulf Inc Fundraise	Walter E. Carter	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	358,450	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Walter E. Carter	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	0	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Catherine J. Motz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	209,241	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Catherine J. Motz	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	0	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Lisa A. Prager	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	310,497	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Lisa A. Prager	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	0	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Michael C. Bucella	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	0	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Michael C. Bucella	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	337,808	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Amanda Fabiano	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	96,792	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Amanda Fabiano	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	56,023	0	-		-	Restricted Stock Units
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.02 per share.	23 Jun 2026	50,530	4,755,109	-	21.0	1,062,141	Common Stock
Clean Energy Fuels Corp	Bartolomeo A. Frabotta	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	50,000	512,886 (0%)	0%		0	Common Stock
Movado Grp Inc	Efraim Grinberg	Director, Chairman - CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.87 per share.	23 Jun 2026	50,000	443,859 (2%)	0%	16.9	843,500	Common Stock
Movado Grp Inc	Efraim Grinberg	Director, Chairman - CEO, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	50,000	50,000	-		-	Employee Stock Option
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	50,000	283,333	-		-	Class B Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	50,000	283,333	-		-	Class B Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	50,000	50,000	-		-	Class A Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	50,000	50,000	-		-	Class A Common Stock
Nuvation Bio Inc (Class A)	Philippe Sauvage	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.17 per share.	23 Jun 2026	47,668	60,341	-	2.2	103,440	Class A Common Stock
Nuvation Bio Inc (Class A)	Philippe Sauvage	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	47,668	702,332	-		-	Stock Option (Right to Buy)
Nuvation Bio Inc (Class A)	Philippe Sauvage	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 6.01 per share.	23 Jun 2026	47,668	12,673	-	6.0	286,370	Class A Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	47,500	47,500	-		-	Class A Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director		23 Jun 2026	47,500	585,833	-		-	Class B Common Stock
Pinterest Inc (Class A)	Benjamin Silbermann	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 19.90 per share.	23 Jun 2026	46,875	0 (0%)	0%	19.9	932,667	Class A Common Stock
Pinterest Inc (Class A)	Benjamin Silbermann	Director, Ten Percent Owner		23 Jun 2026	46,875	46,875 (0%)	0%		0	Class A Common Stock
Pinterest Inc (Class A)	Benjamin Silbermann	Director, Ten Percent Owner		23 Jun 2026	46,875	46,875 (0%)	0%		0	Class A Common Stock
Medicinova Inc	Carolyn D. Beaver	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	44,500	44,500	-		-	Stock Option (Right to Buy)
Medicinova Inc	Hideki Nagao	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	44,500	44,500	-		-	Stock Option (Right to Buy)
Medicinova Inc	Nicole Lemerond	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	44,500	44,500	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	Jason M. Aryeh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	42,553	42,553	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	Christopher Cleary	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	42,553	42,553	-		-	Stock Option (Right to Buy)
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 121.38 per share.	23 Jun 2026	40,774	2,922,833	-	121.4	4,949,148	Common Stock
908 Devices Inc	Kevin J. Knopp	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 9.14 per share.	23 Jun 2026	40,535	752,011	-	9.1	370,490	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 107.10 per share.	23 Jun 2026	40,091	3,326,777	-	107.1	4,293,618	Class A Common Stock
Wendy`s Co (Class A)	Steven W. Cirulis	CFO & Chf Strategy Ofc	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	39,536	39,536	-		-	Restricted Stock Units
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.13 per share.	23 Jun 2026	39,131	1,510,157	-	21.1	826,838	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 119.71 per share.	23 Jun 2026	37,179	3,075,906	-	119.7	4,450,698	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 105.29 per share.	23 Jun 2026	36,751	3,432,107	-	105.3	3,869,362	Class A Common Stock
Movado Grp Inc	Efraim Grinberg	Director, Chairman - CEO, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.69 per share.	23 Jun 2026	36,713	407,146 (2%)	0%	38.7	1,420,426	Common Stock
OneMedNet Corp (Class A)	Aaron Green	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.57 per share.	23 Jun 2026	36,650	1,896,375	-	0.6	21,011	Common Stock
Macy`s Inc	Thomas J. Edwards	EVP, COO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	36,419	109,257	-		-	Restricted Stock Units
Macy`s Inc	Thomas J. Edwards	EVP, COO & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	36,419	36,419 (0%)	0%		-	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 106.04 per share.	23 Jun 2026	35,128	48,490	-	106.0	3,724,949	Class A Common Stock
Accelerant Holdings (Class A)	Nancy Hasley	Director	Sale of securities on an exchange or to another person at price $ 13.11 per share.	23 Jun 2026	35,000	1,362,323	-	13.1	458,948	Class A Common Shares
Orchestra BioMed Holdings Inc	John Mack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	34,653	74,939	-		0	Common Stock, par value $0.0001 per share ("Common Stock")
Nuvation Bio Inc (Class A)	Stacy Markel	CHIEF PEOPLE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share.	23 Jun 2026	34,620	157,591	-	1.7	60,239	Class A Common Stock
Nuvation Bio Inc (Class A)	Stacy Markel	CHIEF PEOPLE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	34,620	220,190	-		-	Stock Option (Right to Buy)
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 29.58 per share.	23 Jun 2026	33,592	102	-	29.6	993,651	Class A Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 29.58 per share.	23 Jun 2026	33,591	102	-	29.6	993,622	Class A Common Stock
Royalty Pharma PLC (Class A)	Christopher Hite	EVP & Chairman, Partnering	Sale of securities on an exchange or to another person at price $ 54.11 per share.	23 Jun 2026	32,408	676,991	-	54.1	1,753,500	Class A Ordinary Shares
Candel Therapeutics Inc	Joseph C. Papa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Paul B. Manning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Edward J. Benz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Mahalakshmi Radhakrishnan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Renee M. Gaeta	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Diem Nguyen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Gary J. Nabel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Christopher Martell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Candel Therapeutics Inc	Nicoletta Loggia	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	32,000	32,000	-		-	Stock Option (Right to Buy)
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 29.58 per share.	23 Jun 2026	31,912	97	-	29.6	943,957	Class A Common Stock
Alto Ingredients Inc	Gilbert E. Nathan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	31,652	806,393 (1%)	0%		0	Common Stock
FibroBiologics Inc	Richard C. Cilento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,803	30,803	-		-	Stock Option (Right to Buy)
FibroBiologics Inc	Robert E. Hoffman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,803	30,803	-		-	Stock Option (Right to Buy)
FibroBiologics Inc	Matthew Link	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,803	30,803	-		-	Stock Option (Right to Buy)
FibroBiologics Inc	Victoria Niklas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,803	30,803	-		-	Stock Option (Right to Buy)
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.13 per share.	23 Jun 2026	30,774	1,106,036	-	21.1	650,255	Common Stock
Monte Rosa Therapeutics Inc	Filip Janku	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 21.42 per share.	23 Jun 2026	30,000	59,992	-	21.4	642,681	Common Stock
Monte Rosa Therapeutics Inc	Filip Janku	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.56 per share.	23 Jun 2026	30,000	89,992	-	7.6	226,800	Common Stock
Monte Rosa Therapeutics Inc	Filip Janku	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	30,000	66,000	-		-	Stock Option (Right to Buy)
Hydrofarm Holdings Grp Inc	Renah Persofsky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,000	91,498	-		0	Common Stock, $0.0001 par value per share
Hydrofarm Holdings Grp Inc	Patrick Chung	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,000	91,148	-		0	Common Stock, $0.0001 par value per share
Hydrofarm Holdings Grp Inc	Melisa A. Denis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,000	88,423	-		0	Common Stock, $0.0001 par value per share
Hydrofarm Holdings Grp Inc	Richard Christopher Yetter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,000	50,000	-		0	Common Stock, $0.0001 par value per share
Daxor Corp	Michael R. Feldschuh	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	30,000	243,694 (6%)	0%		0	Daxor Common Stock
MapLight Therapeutics Inc 10-year high	Martin Babler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	29,804	29,804	-		-	Stock Option (right to buy)
MapLight Therapeutics Inc 10-year high	Troy M. Cox	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	29,804	29,804	-		-	Stock Option (right to buy)
Lovesac Co	Andrew Farag	EVP and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	28,843	28,843	-		-	Restricted Stock Units
LeonaBio Inc	James A. Johnson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	28,000	28,000	-		-	Stock Option (Right to Buy)
LeonaBio Inc	Grant E. Pickering	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	28,000	28,000	-		-	Stock Option (Right to Buy)
LeonaBio Inc	Michael A. Panzara	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	28,000	28,000	-		-	Stock Option (Right to Buy)
LeonaBio Inc	Kelly A. Romano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	28,000	28,000	-		-	Stock Option (Right to Buy)
LeonaBio Inc	Barbara Kosacz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	28,000	28,000	-		-	Stock Option (Right to Buy)
Pinterest Inc (Class A)	Benjamin Silbermann	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 19.84 per share.	23 Jun 2026	26,534	20,341 (0%)	0%	19.8	526,541	Class A Common Stock
Healthcare Realty Trust Inc (Class A)	Amanda L. Callaway	SVP & Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 20.37 per share.	23 Jun 2026	25,767	109,954 (0%)	0%	20.4	524,874	Common Stock
Liberty Global PLC (Class A)	Larry E. Romrell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,624	25,624	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Larry E. Romrell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,624	25,624	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Miranda Curtis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,624	25,624	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Miranda Curtis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,624	25,624	-		-	Share Option C (right to buy)
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.02 per share.	23 Jun 2026	25,397	1,484,760	-	21.0	533,845	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 127.37 per share.	23 Jun 2026	25,075	2,864,885	-	127.4	3,193,803	Common Stock
Acacia Research Corp	Michelle Felman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,052	57,224 (0%)	0%		0	ACTG Common Stock
Acacia Research Corp	Isaac Theodore Kohlberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,052	110,498 (0%)	0%		0	ACTG Common Stock
Acacia Research Corp	Gavin T. Molinelli	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,052	199,528 (0%)	0%		0	Common Stock, par value $0.001
Amplify Energy Corp	James G. Frew	SEE REMARKS	Purchase of securities on an exchange or from another person at price $ 3.95 per share.	23 Jun 2026	25,000	216,859 (0%)	0%	4.0	98,750	Common Stock, par value $0.01 per share
Aquestive Therapeutics Inc	Julie Krop	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share.	23 Jun 2026	25,000	25,000 (0%)	0%	0.7	17,830	Common Stock
Aquestive Therapeutics Inc	Julie Krop	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	25,000	0	-		-	Non-Qualified Stock Option (right to buy)
Aquestive Therapeutics Inc	Julie Krop	Director	Sale of securities on an exchange or to another person at price $ 5.02 per share.	23 Jun 2026	25,000	0 (0%)	0%	5.0	125,393	Common Stock
Daxor Corp	Jonathan Feldschuh	Director, Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	25,000	78,908 (2%)	0%		0	Daxor Common Stock
FREYR Battery	Andreas Bentzen	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	25,000	50,000	-		-	Restricted Stock Units (RSUs)
FREYR Battery	Andreas Bentzen	Chief Technology Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	25,000	25,000	-		-	Common Stock
Titan Intl Inc	Mark H. Rachesky	Director	Grant, award, or other acquisition of securities at price $ 7.28 per share.	23 Jun 2026	24,725	24,725 (0%)	0%	7.3	179,998	Common Stock
Titan Intl Inc	Anthony L. Soave	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	24,725	1,193,348 (1%)	0%		0	Common stock
Titan Intl Inc	Maurice M. Taylor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	24,725	677,356 (1%)	0%		0	Common stock
Titan Intl Inc	Richard M. Cashin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	24,725	251,045 (0%)	0%		0	Common stock
Titan Intl Inc	Max A. Guinn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	24,725	190,061 (0%)	0%		0	Common stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 117.50 per share.	23 Jun 2026	24,268	3,132,174	-	117.5	2,851,490	Common Stock
Alto Ingredients Inc	Dianne S. Nury	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	23,605	241,015 (0%)	0%		0	Common Stock
Alto Ingredients Inc	Maria G. Gray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	23,605	179,229 (0%)	0%		0	Common Stock
Alto Ingredients Inc	Alan R. Tank	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	23,605	60,271 (0%)	0%		0	Common Stock
Darden Restaurants	Ricardo Cardenas	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	23,249	23,249	-		-	Performance Restricted Stock Units (FY24)
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 108.00 per share.	23 Jun 2026	21,933	3,304,844	-	108.0	2,368,856	Class A Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 107.10 per share.	23 Jun 2026	21,588	26,902	-	107.1	2,312,006	Class A Common Stock
Orchestra BioMed Holdings Inc	Eric S. Fain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	21,277	21,277	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	David C. Pacitti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	21,277	21,277	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	Pamela Ann Connealy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	21,277	21,277	-		-	Stock Option (Right to Buy)
Madison Air Solutions Corp	John Joseph Foley	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.13 per share.	23 Jun 2026	21,143	1,641,786	-	38.1	806,183	Class A common stock
Pinterest Inc (Class A)	Benjamin Silbermann	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 20.18 per share.	23 Jun 2026	20,341	0 (0%)	0%	20.2	410,394	Class A Common Stock
Spero Therapeutics Inc	Frank E. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
Spero Therapeutics Inc	John C. Pottage	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
Spero Therapeutics Inc	Milind S. Deshpande	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
Spero Therapeutics Inc	Scott T. Jackson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
Spero Therapeutics Inc	Cynthia Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
Spero Therapeutics Inc	Patrick V.J.J. Vink	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
Spero Therapeutics Inc	Kathleen Tregoning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	20,000	-		-	Stock Option (right to buy)
USA Compression Partners LP - Unit	Christopher W Porter	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	20,000	128,001 (0%)	0%		0	Common Units
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.02 per share.	23 Jun 2026	19,973	1,086,063	-	21.0	419,832	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 105.29 per share.	23 Jun 2026	19,790	83,618	-	105.3	2,083,608	Class A Common Stock
Wealthfront Corp	Andrew S. Rachleff	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	19,446	19,446	-		-	Restricted Stock Units
Wealthfront Corp	Jason Kilar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	19,446	19,446	-		-	Restricted Stock Units
Wealthfront Corp	Kenneth A. Goldman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	19,446	19,446	-		-	Restricted Stock Units
Wealthfront Corp	L. Michelle Wilson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	19,446	19,446	-		-	Restricted Stock Units
Wealthfront Corp	Jaleh Bisharat	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	19,446	19,446	-		-	Restricted Stock Units
Wealthfront Corp	Michael Reed Schmidt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	19,446	19,446	-		-	Restricted Stock Units
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 118.60 per share.	23 Jun 2026	19,089	3,113,085	-	118.6	2,263,955	Common Stock
Vera Therapeutics Inc (Class A)	Marshall Fordyce	Director, PRESIDENT AND CEO	Sale of securities on an exchange or to another person at price $ 37.93 per share.	23 Jun 2026	18,412	198,332	-	37.9	698,387	Class A Common Stock
Orchestra BioMed Holdings Inc	Eric S. Fain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	17,327	109,036	-		0	Common Stock, par value $0.0001 per share ("Common Stock")
Orchestra BioMed Holdings Inc	David C. Pacitti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	17,327	62,295	-		0	Common Stock, par value $0.0001 per share ("Common Stock")
Orchestra BioMed Holdings Inc	Pamela Ann Connealy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	17,327	66,038	-		0	Common Stock, par value $0.0001 per share ("Common Stock")
Macy`s Inc	Thomas J. Edwards	EVP, COO & CFO	Sale of securities on an exchange or to another person at price $ 24.89 per share.	23 Jun 2026	16,419	20,000 (0%)	0%	24.9	408,726	Common Stock
908 Devices Inc	Kevin J. Knopp	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 9.10 per share.	23 Jun 2026	16,388	735,623	-	9.1	149,131	Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 28.95 per share.	23 Jun 2026	16,307	33,693	-	29.0	472,088	Class A Common Stock
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 28.95 per share.	23 Jun 2026	16,306	33,694	-	29.0	472,059	Class A Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 53.13 per share.	23 Jun 2026	15,962	0	-	53.1	848,061	Class A Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	15,962	18,611,131	-		-	Non-voting common units of Alclear Holdings, LLC
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	15,962	0	-		-	Class A Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jun 2026	15,962	151,787	-		-	Class B Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	15,962	167,749	-		-	Class B Common Stock
Clear Secure Inc (Class A)	Caryn Seidman Becker	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jun 2026	15,962	18,611,131	-		-	Class D Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 120.66 per share.	23 Jun 2026	15,660	543,864	-	120.7	1,889,536	Common Stock
NetApp	Cesar Cernuda	President	Sale of securities on an exchange or to another person at price $ 155.29 per share.	23 Jun 2026	15,593	60,100 (0%)	0%	155.3	2,421,437	Common Shares
Oscar Health Inc (Class A)	Mario Schlosser	Director	Sale of securities on an exchange or to another person at price $ 28.95 per share.	23 Jun 2026	15,491	32,009	-	28.9	448,464	Class A Common Stock
Crown Holdings Inc	Timothy J. Donahue	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 105.00 per share.	23 Jun 2026	15,000	436,070 (0%)	0%	105	1,575,000	Common
NetApp	Cesar Cernuda	President	Sale of securities on an exchange or to another person at price $ 154.01 per share.	23 Jun 2026	14,947	75,693 (0%)	0%	154.0	2,301,987	Common Shares
MapLight Therapeutics Inc 10-year high	George Pavlov	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	14,902	14,902	-		-	Stock Option (right to buy)
MapLight Therapeutics Inc 10-year high	Nanna Liebach Luneborg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	14,902	14,902	-		-	Stock Option (right to buy)
MapLight Therapeutics Inc 10-year high	Maria C. Walker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	14,902	14,902	-		-	Stock Option (right to buy)
MapLight Therapeutics Inc 10-year high	Timothy John Garnett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	14,902	14,902	-		-	Stock Option (right to buy)
CarMax	Thomas J. Folliard	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	14,855	0	-		-	Restricted Stock Units
CarMax	Thomas J. Folliard	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.91 per share.	23 Jun 2026	14,855	227,676 (0%)	0%	51.9	771,123	Common Stock
Aspen Aerogels Inc	William P. Noglows	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.75 per share.	23 Jun 2026	14,799	114,156 (0%)	0%	4.7	70,295	Common Stock
Aspen Aerogels Inc	William P. Noglows	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	14,799	0	-		-	Stock Options (Right to Buy)
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 100.42 per share.	23 Jun 2026	14,513	599,076	-	100.4	1,457,395	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 101.14 per share.	23 Jun 2026	14,490	3,343,343	-	101.1	1,465,519	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 108.83 per share.	23 Jun 2026	14,351	3,318,839	-	108.8	1,561,819	Common Stock
Fluent Inc	Donald Patrick	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	14,286	0	-		-	Pre-Funded Warrant
Fluent Inc	Donald Patrick	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	14,286	558,794 (0%)	0%	0.0	7	Common Stock
Neogenomics Inc	Carolyn S. Starrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	14,125	14,125	-		-	Restricted Stock Unit
Clean Energy Fuels Corp	Barclay F. Corbus	Director, PRESIDENT AND CEO	Purchase of securities on an exchange or from another person at price $ 1.77 per share.	23 Jun 2026	14,000	1,350,021 (0%)	0%	1.8	24,811	Common Stock
Liberty Latin America Ltd (Class A)	Charles H.R. Bracken	Director	Other type of transaction at price $ 0.00 per share.	23 Jun 2026	13,967	13,967	-		0	Series A Preference Shares
NetApp	Cesar Cernuda	President	Sale of securities on an exchange or to another person at price $ 155.94 per share.	23 Jun 2026	13,294	46,806 (0%)	0%	155.9	2,073,066	Common Shares
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	J. David Wargo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	J. David Wargo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Richard R. Green	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Richard R. Green	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option C (right to buy)
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,812	12,812	-		-	Share Option A (right to buy)
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.10 per share.	23 Jun 2026	12,699	4,742,410	-	21.1	267,949	Common Stock
Insmed Inc	Samuele Butera	SVP, GM, Global Respiratory	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,570	12,570	-		-	Stock Option (right to buy)
Fluent Inc	Donald Patrick	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	12,502	544,509 (0%)	0%	0.0	6	Common Stock
Fluent Inc	Donald Patrick	Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	12,502	0	-		-	Pre-Funded Warrant
Titan Intl Inc	Laura K. Thompson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,362	59,377 (0%)	0%		0	Common stock
Daxor Corp	Robert J. Michel	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	12,000	33,050 (0%)	0%		0	Daxor Common Stock
FREYR Battery	Andreas Bentzen	Chief Technology Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.24 per share.	23 Jun 2026	11,850	13,150	-	9.2	109,494	Common Stock
Monte Rosa Therapeutics Inc	Filip Janku	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 20.22 per share.	23 Jun 2026	11,845	59,992	-	20.2	239,522	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 108.00 per share.	23 Jun 2026	11,810	15,092	-	108.0	1,275,531	Class A Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 124.61 per share.	23 Jun 2026	11,711	2,895,285	-	124.6	1,459,308	Common Stock
GrabAGun Digital Holdings Inc	Kelly Reisdorf	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Kelly Reisdorf	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	21,433	-		-	Common Stock
GrabAGun Digital Holdings Inc	Andrew J. Keegan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	11,433	-		-	Common Stock
GrabAGun Digital Holdings Inc	Andrew J. Keegan	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Blake Masters	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	11,433	-		-	Common Stock
GrabAGun Digital Holdings Inc	Blake Masters	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Dusty Wunderlich	Former Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Dusty Wunderlich	Former Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	111,433	-		-	Common Stock
GrabAGun Digital Holdings Inc	Donald J. Trump	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Donald J. Trump	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	311,433	-		-	Common Stock
GrabAGun Digital Holdings Inc	Chris W. Cox	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Chris W. Cox	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	11,433	-		-	Common Stock
GrabAGun Digital Holdings Inc	Colion Noir	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	0	-		-	Restricted Stock Units
GrabAGun Digital Holdings Inc	Colion Noir	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	11,433	11,433	-		-	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 116.53 per share.	23 Jun 2026	11,375	570,673	-	116.5	1,325,529	Common Stock
American Fin Grp Inc Dividend	David Lawrence Thompson	Director, President of Subsidiary	Sale of securities on an exchange or to another person at price $ 135.05 per share.	23 Jun 2026	11,370	584,097 (0%)	0%	135.0	1,535,496	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 123.62 per share.	23 Jun 2026	10,860	2,906,996	-	123.6	1,342,513	Common Stock
Ford Motor	John Lawson Thornton	Director	Purchase of securities on an exchange or from another person at price $ 14.05 per share.	23 Jun 2026	10,600	486,685 (0%)	0%	14.0	148,880	Common Stock, $0.01 par value
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 113.70 per share.	23 Jun 2026	10,215	3,305,376	-	113.7	1,161,446	Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 110.25 per share.	23 Jun 2026	10,205	3,286,110	-	110.2	1,125,062	Class A Common Stock
Amplitech Grp Inc	Daniel Richard Mazziota	Director	Sale of securities on an exchange or to another person at price $ 7.71 per share.	23 Jun 2026	10,000	237,743	-	7.7	77,146	Common Stock
Moog Inc (Class A)	John R. Scannell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	10,000	10,000	-		-	SAR
Moog Inc (Class A)	John R. Scannell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.65 per share.	23 Jun 2026	10,000	46,358 (1%)	0%	71.6	716,480	Class B Common
United Natural Foods Inc	Mark Bushway	President, Natural & CSCO	Sale of securities on an exchange or to another person at price $ 51.56 per share.	23 Jun 2026	10,000	51,119 (0%)	0%	51.6	515,600	Common Stock
Spero Therapeutics Inc	Frank E. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	85,000 (0%)	0%		0	Common Stock
Spero Therapeutics Inc	John C. Pottage	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	85,000 (0%)	0%		0	Common Stock
Spero Therapeutics Inc	Milind S. Deshpande	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	101,454 (0%)	0%		0	Common Stock
Spero Therapeutics Inc	Scott T. Jackson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	85,000 (0%)	0%		0	Common Stock
Spero Therapeutics Inc	Cynthia Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	85,000 (0%)	0%		0	Common Stock
Spero Therapeutics Inc	Patrick V.J.J. Vink	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	85,000 (0%)	0%		0	Common Stock
Spero Therapeutics Inc	Kathleen Tregoning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	10,000	85,000 (0%)	0%		0	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 107.30 per share.	23 Jun 2026	9,994	3,333,349	-	107.3	1,072,356	Common Stock
908 Devices Inc	Christopher Brown	Director	Sale of securities on an exchange or to another person at price $ 9.04 per share.	23 Jun 2026	9,900	865,559	-	9.0	89,496	Common Stock
4D Molecular Therapeutics Inc	Scott Bizily	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	9,810	63,785	-		-	Stock Option (Right to Buy)
4D Molecular Therapeutics Inc	Scott Bizily	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 12.00 per share.	23 Jun 2026	9,810	8,617	-	12	117,720	Common Stock
4D Molecular Therapeutics Inc	Scott Bizily	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.14 per share.	23 Jun 2026	9,810	18,427	-	4.1	40,613	Common Stock
Neogenomics Inc	Carolyn S. Starrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	9,784	9,784	-		-	Stock Option (Right to Buy)
ChargePoint Holdings Inc (Class A)	Jagdeep CA. Singh	CCXO	Sale of securities on an exchange or to another person at price $ 7.14 per share.	23 Jun 2026	9,719	187,846	-	7.1	69,350	Common Stock
First Bancorp	Richard H. Moore	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 62.03 per share.	23 Jun 2026	9,673	59,037	-	62.0	600,016	Restricted Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.42 per share.	23 Jun 2026	9,500	50,013 (0%)	0%	135.4	1,286,490	Common Stock
United Therapeutics Corp	Martine A. Rothblatt	Director, Chairperson & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	9,500	134,718	-		-	Stock Option
SEACOR Marine Holdings Inc	Andrew H. Everett	Sr. VP, General Counsel & Secy	Sale of securities on an exchange or to another person at price $ 8.02 per share.	23 Jun 2026	9,435	284,160 (1%)	0%	8.0	75,669	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 114.65 per share.	23 Jun 2026	9,229	3,296,147	-	114.7	1,058,105	Common Stock
Protagonist Therapeutics Inc	William D. Waddill	Director	Sale of securities on an exchange or to another person at price $ 117.94 per share.	23 Jun 2026	9,000	7,825 (0%)	0%	117.9	1,061,460	Common Stock
Protagonist Therapeutics Inc	William D. Waddill	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.54 per share.	23 Jun 2026	9,000	16,825 (0%)	0%	16.5	148,860	Common Stock
Protagonist Therapeutics Inc	William D. Waddill	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	9,000	0	-		-	Stock Option (right to buy)
La-Z-Boy Inc	Michael A. Leggett	Sr VP & Chief Supply Chain Off	Sale of securities on an exchange or to another person at price $ 41.66 per share.	23 Jun 2026	9,000	47,551 (0%)	0%	41.7	374,918	Common Shares
ServiceTitan Inc (Class A)	Byron B. Deeter	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 65.26 per share.	23 Jun 2026	8,845	4,937	-	65.3	577,225	Class A Common Stock
ServiceTitan Inc (Class A)	Byron B. Deeter	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 63.35 per share.	23 Jun 2026	8,845	13,782	-	63.4	560,331	Class A Common Stock
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 109.17 per share.	23 Jun 2026	8,529	3,296,315	-	109.2	931,069	Class A Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 115.57 per share.	23 Jun 2026	8,389	582,048	-	115.6	969,517	Common Stock
CoStar	Christine M McCarthy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	11,585 (0%)	0%		0	Common Stock, par value $0.01 per share
CoStar	John L. Berisford	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	11,235 (0%)	0%		0	Common Stock, par value $0.01 per share
CoStar	John W. Hill	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	26,493 (0%)	0%		0	Common Stock, par value $0.01 per share
CoStar	Robert W. Musslewhite	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	26,539 (0%)	0%		0	Common Stock, par value $0.01 per share
CoStar	Louise S. Sams	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	28,671 (0%)	0%		0	Common Stock, par value $0.01 per share
CoStar	Rachel Glaser	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	12,419 (0%)	0%		0	Common Stock, par value $0.01 per share
CoStar	Angelique G. Brunner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	8,262	18,428 (0%)	0%		0	Common Stock, par value $0.01 per share
Hallador Energy Co	Todd E. Telesz	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	8,219	32,686	-		-	Restricted Stock Unit
Hallador Energy Co	Todd E. Telesz	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.73 per share.	23 Jun 2026	8,219	8,219 (0%)	0%	17.7	145,723	Common Stock
ChargePoint Holdings Inc (Class A)	Mansi Khetani	CFO	Sale of securities on an exchange or to another person at price $ 7.14 per share.	23 Jun 2026	8,152	179,348	-	7.1	58,165	Common Stock
MapLight Therapeutics Inc 10-year high	Martin Babler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,864	7,864	-		0	Voting Common Stock
MapLight Therapeutics Inc 10-year high	Troy M. Cox	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,864	7,864	-		0	Voting Common Stock
TeraWulf Inc Fundraise	Steven T. Pincus	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,818	7,818	-		-	Restricted Stock Units
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 111.05 per share.	23 Jun 2026	7,800	3,278,310	-	111.0	866,171	Class A Common Stock
First Bancorp	Gregory A. Currie	Director, Chief Exec. Officer-First Bank	Grant, award, or other acquisition of securities at price $ 62.03 per share.	23 Jun 2026	7,739	33,118	-	62.0	480,050	Restricted Stock
National Research Corp	John N. Nunnelly	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,697	40,363 (0%)	0%		0	Common Stock
National Research Corp	Donald M. Berwick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,697	7,697 (0%)	0%		0	Common Stock
National Research Corp	Stephen H. Lockhart	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,697	7,697 (0%)	0%		0	Common Stock
National Research Corp	Penny Ann Wheeler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,697	7,697 (0%)	0%		0	Common Stock
National Research Corp	Parul Bhandari	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,697	7,697 (0%)	0%		0	Common Stock
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	7,557	32,500	-		-	Stock option (right to buy)
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 3.14 per share.	23 Jun 2026	7,557	0 (0%)	0%	3.1	23,729	Common Stock
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.23 per share.	23 Jun 2026	7,557	7,557 (0%)	0%	1.2	9,295	Common Stock
Insmed Inc	Samuele Butera	SVP, GM, Global Respiratory	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	7,342	7,342 (0%)	0%		-	Common Stock
Advantage Soln Inc (Class A)	Christopher Growe	Chief Financial Officer	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jun 2026	7,202	16,962	-		0	Class A Common Stock
Advantage Soln Inc (Class A)	Christopher Growe	Chief Financial Officer	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jun 2026	7,202	34,340	-		0	Class A Common Stock
Credo Tech Grp Holding Ltd	Yat Tung Lam	Director, Chief Operating Officer	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jun 2026	7,000	2,646,969	-		0	Ordinary Shares
TeraWulf Inc Fundraise	Walter E. Carter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	6,950	6,950	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Catherine J. Motz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	6,950	6,950	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Lisa A. Prager	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	6,950	6,950	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Michael C. Bucella	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	6,950	6,950	-		-	Restricted Stock Units
TeraWulf Inc Fundraise	Amanda Fabiano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	6,950	6,950	-		-	Restricted Stock Units
Toro Co.	Kurt D. Svendsen	VP, Technology	Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.54 per share.	23 Jun 2026	6,600	18,766 (0%)	0%	56.5	373,164	Common Stock
Toro Co.	Kurt D. Svendsen	VP, Technology	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	6,600	0	-		-	Non-Qualified Stock Option
Toro Co.	Kurt D. Svendsen	VP, Technology	Sale of securities on an exchange or to another person at price $ 93.09 per share.	23 Jun 2026	6,600	12,166 (0%)	0%	93.1	614,394	Common Stock
PC Connection Inc 10-year high	Patricia Gallup	Director, Chairman & Chief Admin Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 70.04 per share.	23 Jun 2026	6,576	7,014,029 (26%)	0%	70.0	460,583	Common Stock
EPR Properties	Paul Robert Turvey	SVP, General Counsel	Sale of securities on an exchange or to another person at price $ 58.20 per share.	23 Jun 2026	6,400	46,189 (0%)	0%	58.2	372,480	Common Shares of Beneficial Interest
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.10 per share.	23 Jun 2026	6,382	1,478,378	-	21.1	134,660	Common Stock
La-Z-Boy Inc	Melinda D. Whittington	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.30 per share.	23 Jun 2026	6,224	408,837 (0%)	0%	40.3	250,827	Common Shares
Monte Rosa Therapeutics Inc	Filip Janku	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.56 per share.	23 Jun 2026	6,000	71,837	-	7.6	45,360	Common Stock
Monte Rosa Therapeutics Inc	Filip Janku	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	6,000	96,000	-		-	Stock Option (Right to Buy)
Moog Inc (Class A)	John R. Scannell	Director	Payment of exercise price or tax liability using portion of securities received from the company at price $ 416.00 per share.	23 Jun 2026	5,972	40,386 (0%)	0%	416	2,484,352	Class B Common
Darden Restaurants	Rajesh Vennam	SVP, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,890	5,890	-		-	Performance Restricted Stock Units (FY24)
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	14,031 (0%)	0%		-	Class A Common Shares
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	14,031 (0%)	0%		-	Class C Common Shares
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	J. David Wargo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	J. David Wargo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	120,441 (0%)	0%		-	Class C Common Shares
Liberty Global PLC (Class A)	J. David Wargo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	59,685 (0%)	0%		-	Class A Common Shares
Liberty Global PLC (Class A)	J. David Wargo	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Richard R. Green	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Richard R. Green	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	8,757	-		-	Class A Share Fund Units
Liberty Global PLC (Class A)	Richard R. Green	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	11,419	-		-	Class C Share Fund Units
Liberty Global PLC (Class A)	Richard R. Green	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	42,790	-		-	Class C Share Fund Units
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	27,752	-		-	Class A Share Fund Units
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	24,989 (0%)	0%		-	Class A Common Shares
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	45,746 (0%)	0%		-	Class C Common Shares
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	15,876 (0%)	0%		-	Class C Common Shares
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	12,509 (0%)	0%		-	Class A Common Shares
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	9,398 (0%)	0%		-	Class C Common Shares
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	0	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jun 2026	5,809	7,606 (0%)	0%		-	Class A Common Shares
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 121.38 per share.	23 Jun 2026	5,689	538,175	-	121.4	690,531	Common Stock
NetApp	Cesar Cernuda	President	Sale of securities on an exchange or to another person at price $ 153.00 per share.	23 Jun 2026	5,630	90,640 (0%)	0%	153	861,390	Common Shares
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 110.25 per share.	23 Jun 2026	5,495	5,005	-	110.2	605,802	Class A Common Stock
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Anthony G. Werner	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	J. David Wargo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	J. David Wargo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Richard R. Green	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Richard R. Green	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Paul Alan Gould	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Andrew J. Cole	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Daniel E. Sanchez	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units C
Liberty Global PLC (Class A)	Marisa Danielle Drew	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jun 2026	5,230	5,230	-		-	Restricted Share Units A
CoreWeave Inc (Class A)	Michael Intrator	Director, CEO and President, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 103.94 per share.	23 Jun 2026	5,162	3,468,858	-	103.9	536,549	Class A Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 119.71 per share.	23 Jun 2026	5,144	559,524	-	119.7	615,788	Common Stock
Dyne Therapeutics Inc	Jason P. Rhodes	Director	Sale of securities on an exchange or to another person at price $ 21.10 per share.	23 Jun 2026	5,019	1,081,044	-	21.1	105,901	Common Stock
Outfront Media Inc	Richard H. Sauer	EVP, General Counsel	Sale of securities on an exchange or to another person at price $ 32.08 per share.	23 Jun 2026	5,000	56,947 (0%)	0%	32.1	160,400	Common Stock
ChargePoint Holdings Inc (Class A)	Eric Batill	General Counsel	Sale of securities on an exchange or to another person at price $ 7.13 per share.	23 Jun 2026	4,979	143,631	-	7.1	35,523	Common Stock
Kymera Therapeutics Inc	Bruce Booth	Director	Sale of securities on an exchange or to another person at price $ 122.67 per share.	23 Jun 2026	4,977	2,917,856	-	122.7	610,529	Common Stock
Liberty Latin America Ltd (Class A)	Charles H.R. Bracken	Director	Purchase of securities on an exchange or from another person at price $ 20.50 per share.	23 Jun 2026	4,900	23,767	-	20.5	100,450	Series A Preference Shares
Liberty Latin America Ltd (Class A)	Charles H.R. Bracken	Director	Purchase of securities on an exchange or from another person at price $ 20.50 per share.	23 Jun 2026	4,900	18,867	-	20.5	100,450	Series A Preference Shares

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jun 23, 2026

Monitor US insider transactions and discover insider buying and selling of stocks on Jun 23, 2026.

The latest disclosure under SEC insider trading regulations was reported by Expensify Inc - Ordinary Shares - Class A., where the revocation of 2,094,974 Stock Option of common stock was executed . This transaction was reported to the Securities and Exchange Commission on June 23, 2026.

Screeners based on Insider Trading parameters